Biomeostasis is a specialized contract research firm providing customized in vivo primary and secondary pharmacodynamic studies on relevant healthy and pathophysiological mouse models to assess and predict the effectiveness, safety, and mode of action for new medications and nutritional supplements targeting nutritional behavior and correlated metabolic ailments such as obesity, anorexia, diabetes, and gastrointestinal disorders. Biomeostasis also engages in its own research and development initiatives with collaborators to continually enhance its service offerings in the field of nutritional behavior and related metabolic disorders.